startup-valuation

Startup valuation methods — pre/post-money, VC method, comparables.

When to Activate

• Valuing an early-stage or growth-stage company for a funding round
• Negotiating pre-money valuation with founders or investors
• Applying the VC method to estimate required ownership for target returns
• Selecting comparable companies and appropriate multiples for startups
• Evaluating a startup valuation for 409A, IFRS, or tax purposes
• Assessing dilution impact across multiple funding rounds
• Challenging or defending a valuation in investment committee materials

Core Concepts

Pre-Money / Post-Money Mechanics

The fundamental equation of venture financing:

Post-Money Valuation = Pre-Money Valuation + Investment Amount
Investor Ownership % = Investment Amount / Post-Money Valuation

• Pre-money valuation: The agreed value of the company immediately before the new investment. Reflects existing shareholders' implied value
• Post-money valuation: Pre-money plus the new capital raised. The investor's ownership is determined by their investment as a fraction of post-money
• Option pool shuffle: If the term sheet specifies that an option pool be created (or expanded) on a pre-money basis, existing shareholders bear the dilution. A 15% option pool on a $10M pre-money effectively values the operating company at $8.5M
• Convertible notes / SAFEs: Convert at a discount to the next priced round or at a valuation cap. The effective pre-money depends on the conversion terms — always model the fully diluted cap table

VC Method

Developed by William Sahlman at HBS. Works backward from the expected exit to determine the required ownership today.

Steps:

1. Estimate terminal value: Project revenue or earnings at the expected exit date (typically 5-7 years). Apply an appropriate exit multiple
2. Determine target return: VCs typically target 10-30x on early-stage, 3-5x on growth-stage, reflecting the high failure rate
3. Calculate required ownership at exit: Required ownership = Investment / (Terminal Value / Target Multiple) — or more directly: Investment * Target Return / Terminal Value
4. Adjust for future dilution: If the company will raise additional rounds, the investor's stake will be diluted. Retention ratio = 1 / (1 + dilution per round)^(number of rounds). Divide required exit ownership by the retention ratio to get required ownership today
5. Derive pre-money: Pre-money = (Investment / Required Ownership) - Investment

Example:

Investment:           $5M
Expected exit value:  $200M (5 years, revenue multiple)
Target return:        10x (so need $50M at exit)
Required exit ownership: $50M / $200M = 25%
Expected dilution:    Two more rounds, 20% each → retention = (1-0.20)^2 = 64%
Required ownership today: 25% / 64% = 39.1%
Post-money: $5M / 39.1% = $12.8M
Pre-money: $12.8M - $5M = $7.8M

Comparable Company Approach for Startups

Adapting public market comparables for private startups:

• Revenue multiples: EV/Revenue is the primary metric for pre-profit startups. Select comparables based on business model, growth rate, market, and stage
• Growth-adjusted multiples: EV/Revenue divided by revenue growth rate. Normalizes for growth differentials between the subject and comparables
• Discount for illiquidity: Private company valuations typically apply a 20-40% discount to public market multiples (lack of marketability)
• Discount for size/stage risk: Smaller, earlier-stage companies warrant additional discounts for execution risk, customer concentration, key-person dependence
• Sector benchmarks: SaaS (6-15x ARR for high-growth), fintech (5-12x revenue), biotech (pipeline-based, milestone-adjusted), marketplace (1-5x GMV or 5-20x take-rate revenue)

Revenue Multiples Deep Dive

For SaaS and recurring-revenue businesses:

• ARR (Annual Recurring Revenue): The standard base for SaaS valuation. More reliable than total revenue which may include services
• Rule of 40: Revenue growth rate + EBITDA margin >= 40% indicates a well-run SaaS business. Companies above this threshold command premium multiples
• Net Revenue Retention (NRR): > 120% signals strong expansion within existing customers — drives higher multiples
• CAC Payback / LTV:CAC: Efficiency metrics that influence investor willingness to pay premium multiples
• Multiple ranges (as of typical market conditions):
  • NRR > 130%, growth > 50%: 15-25x ARR
  • NRR 110-130%, growth 30-50%: 8-15x ARR
  • NRR 100-110%, growth 15-30%: 5-8x ARR
  • NRR < 100%, growth < 15%: 2-5x ARR

Berkus Method

Pre-revenue valuation framework assigning up to $500K for each of five risk-reducing factors:

Factor                              Value (up to)
Sound idea (basic value)            $500K
Prototype (technology risk reduced) $500K
Quality management team             $500K
Strategic relationships             $500K
Product rollout / early sales       $500K
Maximum pre-money:                  $2.5M

Best suited for very early stage (pre-seed, seed). Provides a structured framework for what is inherently a qualitative judgment.

Risk Factor Summation

Adjusts a base valuation by scoring twelve risk factors:

1. Management risk
2. Stage of business
3. Legislation / political risk
4. Manufacturing risk
5. Sales and marketing risk
6. Funding / capital risk
7. Competition risk
8. Technology risk
9. Litigation risk
10. International risk
11. Reputation risk
12. Potential lucrative exit

Each factor scored: -- (-$500K), - (-$250K), 0 (neutral), + (+$250K), ++ (+$500K)

Start with the average pre-money valuation for similar stage/sector companies in the region, then adjust.

Milestone-Based Valuation

Valuation increases are tied to the achievement of specific milestones:

• Technical milestones: MVP complete, beta launched, product-market fit demonstrated
• Commercial milestones: First customer, $1M ARR, 100 customers, positive unit economics
• Team milestones: Key hires (CTO, VP Sales), advisory board assembled
• Regulatory milestones: Approval, license, certification obtained

Each milestone reduces execution risk and justifies a step-up in valuation. Tranched investment structures tie funding releases to milestone achievement.

Methodology

1. Stage assessment: Determine the company's stage (pre-seed, seed, Series A/B/C, growth) — this dictates which methods are most appropriate
2. Financial data gathering: Collect revenue (or ARR), growth rate, burn rate, unit economics, and projections. For pre-revenue, gather product and team data
3. Method selection: Apply 2-3 methods appropriate to the stage:
   • Pre-revenue: Berkus, Risk Factor Summation, comparable seed rounds
   • Seed/Series A: VC method, comparable transactions, revenue multiples (if revenue exists)
   • Series B+: Revenue multiples, comparable companies, DCF with scenario analysis, VC method as a cross-check
4. Comparable analysis: Identify 5-10 comparable companies or transactions. Adjust for growth, profitability, market, and stage differences
5. Triangulation: Weigh the outputs of each method. Explain the rationale for the weighting
6. Dilution modeling: Model the cap table through the current round and anticipated future rounds
7. Sensitivity analysis: Show valuation under different exit assumptions, growth scenarios, and multiple environments

Templates

VC Method Valuation

Company: [Name]            Stage: Series A           Date: [Date]

Exit Assumptions:
  Exit year:                Year 5
  Projected revenue at exit: $80M
  Exit multiple (EV/Revenue): 6.0x (median of comparable exits)
  Terminal value:            $480M

Investment & Return:
  Investment amount:         $8M
  Target return multiple:    8x
  Required proceeds:         $64M
  Required exit ownership:   $64M / $480M = 13.3%

Dilution Adjustment:
  Expected future rounds:    Series B ($20M at $100M post), Series C ($40M at $350M post)
  Cumulative dilution:       ~30%
  Retention ratio:           70%
  Required ownership today:  13.3% / 70% = 19.0%

Implied Valuation:
  Post-money:                $8M / 19.0% = $42.1M
  Pre-money:                 $42.1M - $8M = $34.1M

Sensitivity:
  Exit Multiple    5.0x     6.0x     8.0x     10.0x
  Pre-money ($M)   23.3     34.1     55.7     77.3

Comparable Transaction Analysis

Company       | Stage   | Date    | Round Size | Pre-Money | Rev Run-Rate | EV/Rev | Growth
--------------|---------|---------|-----------|-----------|-------------|--------|-------
Comp A        | Series A| Q2 2025 | $10M      | $35M      | $4M         | 8.8x   | 120%
Comp B        | Series A| Q1 2025 | $12M      | $48M      | $8M         | 6.0x   | 80%
Comp C        | Series A| Q4 2024 | $7M       | $25M      | $3M         | 8.3x   | 150%
Comp D        | Series A| Q3 2024 | $15M      | $55M      | $10M        | 5.5x   | 60%

Median EV/Revenue:  7.2x
Subject Revenue:    $5M (ARR), Growth: 100%

Indicated valuation: $5M * 7.2x = $36M (pre-money)
Growth adjustment:   Subject above median growth → justified premium of ~10-15%
Adjusted range:      $36M - $41M pre-money

Valuation Summary and Triangulation

Method                  | Pre-Money ($M) | Weight | Weighted ($M)
------------------------|----------------|--------|---------------
VC Method               | $34.1          | 40%    | $13.6
Comparable Transactions | $38.0          | 35%    | $13.3
Revenue Multiple        | $36.0          | 25%    | $9.0
                        |                |        |
Blended Pre-Money:      |                |        | $35.9M

Recommended range: $33M - $38M pre-money
Central estimate:  $36M

Quality Gate

• Stage-appropriate valuation methods applied (at least two for cross-validation)
• Pre-money / post-money arithmetic verified, including option pool impact
• VC method assumptions documented: exit year, terminal value, target return, dilution forecast
• Comparable companies or transactions selected with explicit criteria and adjustments justified
• Illiquidity and size/stage discounts applied and quantified
• Revenue metrics validated (ARR vs. total revenue, one-time vs. recurring)
• Growth rate, retention, and unit economics benchmarked against comparables
• Cap table modeled through the proposed round showing all share classes
• Sensitivity analysis covers at least exit multiple and growth rate variation
• Valuation triangulation completed with explicit weighting rationale
• Documentation sufficient for 409A, tax, or regulatory purposes if applicable